Incidence and risk factors for herpes zoster following heart transplantation
- 23 October 2013
- journal article
- research article
- Published by Wiley in Transplant Infectious Disease
- Vol. 16 (1) , 17-25
Abstract
Background: Data on the incidence, timing, and risk factors for herpes zoster (HZ) in heart transplant (HT) recipients are limited.Methods: We determined HZ incidence rates and actuarial estimates of time to first HZ episode in 314 HT recipients at our institution from 1995 to 2010. We developed Cox models to assess potential risk factors for HZ in HT.Results: Median age at HT was 54 (range, 17–71) years; 237 (76%) were male. There were 60 episodes of HZ in 51 patients, with an overall incidence rate of 31.6 cases (95% confidence interval [CI], 23.5–41.6)/1000 person‐years. Although most cases occurred during the first post‐HT year, cumulative HZ incidence was 0.078 at 1, 0.15 at 5, and 0.20 at 10 years. Many patients had substantial HZ morbidity, including 14% with HZ ophthalmicus and 45% with post‐herpetic neuralgia. Adjusting for age, gender, and acute cellular rejection episodes, exposure to mycophenolate mofetil (MMF) was an independent risk factor for HZ (adjusted hazard ratio [HR] 2.18; 95% CI, 1.20–3.96; P = 0.01), while ganciclovir‐based cytomegalovirus prophylaxis reduced HZ risk (adjusted HR 0.09; 95% CI, 0.01–0.71; P = 0.02). Although age and female gender increased HZ risk, the magnitude of their effect was not statistically significant in Cox models.Conclusions: HZ is common and morbid after HT, particularly with MMF exposure. Ganciclovir prophylaxis is effective in reducing the short‐term risk of HZ, but the steady incidence of cases for years post HT makes long‐term HZ prevention challenging. Augmenting varicella zoster virus immunity post HT with vaccines warrants further exploration.Keywords
This publication has 37 references indexed in Scilit:
- Herpes zoster incidence in a multicenter cohort of solid organ transplant recipientsTransplant Infectious Disease, 2011
- Infectious and Non-Infectious Neurologic Complications in Heart Transplant RecipientsMedicine, 2010
- Varicella Zoster Virus (VZV) in Solid Organ Transplant RecipientsAmerican Journal of Transplantation, 2009
- Herpes Zoster After Lung Transplantation: Incidence, Timing, and OutcomeThe Annals of Thoracic Surgery, 2009
- Risk of herpes zoster infection in patients with pemphigus on mycophenolate mofetilBritish Journal of Dermatology, 2008
- Incidence and Clinical Characteristics of Herpes Zoster After Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Herpes zoster after liver transplantation: Incidence, risk factors, and complicationsLiver Transplantation, 2004
- Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrationsTransplant Infectious Disease, 2003
- Mycophenolic acid for psoriasisJournal of the American Academy of Dermatology, 1987
- Cellular Immunity and Herpesvirus Infections in Cardiac-Transplant PatientsNew England Journal of Medicine, 1977